Clinical Trial Update: Magnesium Sulfate as an Adjuvant to Lidocaine in MPDS Trigger Point Injections Assessed by VAS and sEMG. [NA]

View source ↗

Summary

Clinical trial at Cairo University evaluating magnesium sulfate as an adjuvant to lidocaine for trigger point injections in myofascial pain syndrome, with outco…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Myofascial Pain Syndrome

Drugs mentioned

• Lidocaine (Lidocaine)
• Magnesium sulfate (magnesium sulfate)

Snippet

Sponsor: Cairo University | Conditions: Myofascial Pain Dysfunction Syndrome | NA | Status: RECRUITING